SI-BONE, Inc.
General ticker "SIBN" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $666.9M (TTM average)
SI-BONE, Inc. follows the US Stock Market performance with the rate: 28.3%.
Estimated limits based on current volatility of 1.4%: low 19.00$, high 19.55$
Factors to consider:
- Total employees count: 349 (+1.5%) as of 2024
- US accounted for 94.8% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Supply chain disruptions, Strategic risks and growth management, Geopolitical risks, Security breaches, AI risks
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [8.29$, 17.76$]
- 2025-12-31 to 2026-12-31 estimated range: [7.52$, 16.29$]
Financial Metrics affecting the SIBN estimates:
- Negative: with PPE of -17.8 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -2.22 <= 0.33
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 72.46 > 63.39
Short-term SIBN quotes
Long-term SIBN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $106.41MM | $138.89MM | $167.18MM |
| Operating Expenses | $166.02MM | $185.82MM | $202.43MM |
| Operating Income | $-59.61MM | $-46.93MM | $-35.25MM |
| Non-Operating Income | $-1.65MM | $3.60MM | $4.33MM |
| Interest Expense | $2.82MM | $3.46MM | $3.44MM |
| R&D Expense | $13.63MM | $15.03MM | $16.56MM |
| Income(Loss) | $-61.26MM | $-43.34MM | $-30.91MM |
| Profit(Loss)* | $-61.26MM | $-43.34MM | $-30.91MM |
| Stockholders Equity | $98.30MM | $169.38MM | $166.96MM |
| Inventory | $17.28MM | $20.25MM | $27.07MM |
| Assets | $157.55MM | $230.43MM | $230.44MM |
| Operating Cash Flow | $-41.66MM | $-18.71MM | $-12.43MM |
| Capital expenditure | $9.51MM | $7.80MM | $10.50MM |
| Investing Cash Flow | $-2.81MM | $-59.80MM | $12.62MM |
| Financing Cash Flow | $2.20MM | $90.93MM | $1.96MM |
| Earnings Per Share** | $-1.79 | $-1.13 | $-0.75 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.